Acadia Pharmaceuticals (ACAD) Debt Ratio (2010 - 2012)

Acadia Pharmaceuticals (ACAD) posted quarterly Debt Ratio of 0.0 for Q1 2012, down 16.75% quarter-over-quarter from 0.0 in Q4 2011.

Acadia Pharmaceuticals (ACAD) Debt Ratio (2010 - 2012) Analysis & Trends

Acadia Pharmaceuticals' Debt Ratio history runs 3 years deep, the most recent figure standing at 0.0 for Q1 2012.

In Q1 2012, Debt Ratio changed N/A year-over-year to 0.0; the TTM figure through Mar 2012 stood at 0.0 (changed N/A YoY), while the FY2011 annual figure was 0.0, down 50.95% from the prior year.
Debt Ratio for Q1 2012 stood at 0.0, down from 0.0 in the prior quarter.
The five-year high for Debt Ratio was 0.0 in Q4 2010, with the low at 0.0 in Q1 2012.
The 3-year median for Debt Ratio is 0.0 (2011), against an average of 0.0.
Peak annual rise in Debt Ratio reached 50.95% in 2011, while the deepest fall reached 50.95% in 2011.
Acadia Pharmaceuticals' Debt Ratio stood at 0.0 in 2010, then sank by 50.95% to 0.0 in 2011, then retreated by 16.75% to 0.0 in 2012.
Business Quant data shows ACAD's Debt Ratio at 0.0 in Q1 2012, 0.0 in Q4 2011, and 0.0 in Q3 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	0.05
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	0.12
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	0.47
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	0.26
10	Acadia Pharmaceuticals	4.86 Bn	3.90 Bn	279.64 Mn	-

Download Data